65
Growth Score
pts
Heat Score
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
324019
Adrenas Therapeutics develops gene therapies for congenital adrenal hyperplasia, focusing on innovative clinical trials.
About the Company
Adrenas Therapeutics focuses on the development of gene therapies for the treatment of congenital adrenal hyperplasia (CAH), a monogenic disease that manifests in childhood. The company collaborates with scientists, physicians, and patients to advance its mission of creating effective gene therapy solutions. Adrenas Therapeutics is actively
involved in clinical trials, including the ADventure investigational gene therapy clinical trial for adults with Classic CAH. Their research includes the use of Intravenous AAV5 Gene Therapy with Human CYP21A2, which has shown promising results in correcting phenotypic deficiencies in the 21-hydroxylase knockout mouse model.
